sp should be 5x imho, page-561

We need to remember Amgen was recently approved by the FDA, they target Kras only and just for Lung cancer. PTX100 targets. K-ras, N-ras and Rhoa and in a basket study of multiple solid tumor cancers.

I don't see the madness stopping. Still only 130m market cap. Speculation only but if there is a trading halt in the morning - what a great way to release results in a webinar tomorrow. It will give plenty of time to digest the results before trading halt opens. The slightest wiff of safety and that's a great sign. But.. If they do announce a registration study" the sky's the limit.
I wont be letting go of any shares even after results... Also wonder if SYC will be announcing the stealth mode Omnicar targets in the webinar tomorrow another reason to topup IMO!

Exciting times for shareholders and patients!